Ciska Buijs

Summary

Affiliation: University Medical Center Groningen
Country: The Netherlands

Publications

  1. ncbi The influence of endocrine treatments for breast cancer on health-related quality of life
    Ciska Buijs
    Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, P O Box 30001, 9700 RB Groningen, The Netherlands
    Cancer Treat Rev 34:640-55. 2008
  2. ncbi Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study
    Ciska Buijs
    Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Breast Cancer Res Treat 115:573-80. 2009
  3. ncbi Effect of tamoxifen on the endometrium and the menstrual cycle of premenopausal breast cancer patients
    Ciska Buijs
    Department of Medical Oncology, University Medical Center Groningen, University of Groningen, The Netherlands
    Int J Gynecol Cancer 19:677-81. 2009
  4. ncbi Hot flushes in breast cancer patients
    Constantijne H Mom
    Department of Medical Oncology, University Medical Center, P.O. Box 30001, 9700 RB Groningen, The Netherlands
    Crit Rev Oncol Hematol 57:63-77. 2006
  5. ncbi Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study
    Peter Nieboer
    University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    J Clin Oncol 23:8296-304. 2005

Collaborators

  • Emile E Voest
  • Nanno H Mulder
  • Constantijne H Mom
  • Elisabeth G E de Vries
  • Peter Nieboer
  • Marian J E Mourits
  • Pax H B Willemse
  • Harm Van Tinteren
  • Sjoerd Rodenhuis
  • Elsken van der Wall
  • Louk V A M Beex
  • Caroline Seynaeve
  • Dick J Richel
  • Pierre Hupperets
  • Els M TenVergert
  • Winette T A van der Graaf
  • Marianne A Nooij

Detail Information

Publications5

  1. ncbi The influence of endocrine treatments for breast cancer on health-related quality of life
    Ciska Buijs
    Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, P O Box 30001, 9700 RB Groningen, The Netherlands
    Cancer Treat Rev 34:640-55. 2008
    ..HRQoL during progestins and the SERM fulvestrant has been compared to this during aromatase inhibitors, and a large number of studies on HRQoL during endocrine therapy will be discussed...
  2. ncbi Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study
    Ciska Buijs
    Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Breast Cancer Res Treat 115:573-80. 2009
    ..We compared venlafaxine and clonidine for the treatment of HF with regard to side effects, efficacy, quality of life and sexual functioning...
  3. ncbi Effect of tamoxifen on the endometrium and the menstrual cycle of premenopausal breast cancer patients
    Ciska Buijs
    Department of Medical Oncology, University Medical Center Groningen, University of Groningen, The Netherlands
    Int J Gynecol Cancer 19:677-81. 2009
    ..This study aimed to investigate the influence of tamoxifen on the menstrual cycle and serum hormone levels and the subsequent endometrial response in premenopausal breast cancer patients...
  4. ncbi Hot flushes in breast cancer patients
    Constantijne H Mom
    Department of Medical Oncology, University Medical Center, P.O. Box 30001, 9700 RB Groningen, The Netherlands
    Crit Rev Oncol Hematol 57:63-77. 2006
    ..However, studies on interaction between SSRIs and tamoxifen may influence future recommendations...
  5. ncbi Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study
    Peter Nieboer
    University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    J Clin Oncol 23:8296-304. 2005
    ..CONCLUSION: In 3 years after treatment, no significant differences in fatigue were found between standard and high-dose chemotherapy. Fatigue did not change over time. The strongest fatigue predictor was poor mental health...